BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 12/22/1999

Atipamezole; Technical Amendment

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect that Orion Corp. is the correct sponsor of a new animal drug application (NADA) for Atipamezole Injection. When FDA issued the regulation reflecting the NADA approval, Pfizer, Inc., the U.S. agent for Orion Corp., was incorrectly listed as the sponsor of the application. This document corrects that error.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →